Effects of Myofascial Release Technique along with Cognitive Behavior Therapy in University Students with Chronic Neck Pain and Forward Head Posture: A Randomized Clinical Trial.
Sahreen AnwarJunaid ZahidCristina Ioana AlexeAbdullah GhaziGabriel MareșZainab SherazRubén Sanchez-GomezWajida PerveenDan Iulian AlexeQais GasibatPublished in: Behavioral sciences (Basel, Switzerland) (2024)
The purpose of this randomized controlled trial was to evaluate the effectiveness of the Myofascial Release Technique (MRT) along with Cognitive Behavioral Therapy (CBT) on pain, craniovertebral angle (CVA), and neck disability in university students with chronic neck pain and forward head posture. A total of sixty-six eligible participants with chronic neck pain and forward head posture were randomized into the Myofascial Release Therapy (MRT) group ( n = 33) and MRT and Cognitive Behavior Therapy (CBT) group (n = 33). Clinical outcomes included neck pain measured using the numerical pain rating scale, neck disability measured through the neck disability index, and forward head posture measured through the cranial vertebral angle. The outcomes were assessed at baseline and the four and eight weeks after the intervention. Both groups showed significant improvement in pain intensity, CVA, and neck disability after the intervention. However, the CBT group demonstrated greater improvements than the MRT group. The difference in outcomes between the groups was statistically significant. Myofascial Release Therapy combined with CBT is an effective treatment method for patients with chronic neck pain and forward head posture.
Keyphrases
- randomized controlled trial
- multiple sclerosis
- chronic pain
- optic nerve
- pain management
- neuropathic pain
- high resolution
- study protocol
- type diabetes
- systematic review
- adipose tissue
- clinical trial
- mass spectrometry
- cell therapy
- body composition
- spinal cord injury
- obsessive compulsive disorder
- metabolic syndrome
- double blind
- botulinum toxin
- spinal cord
- weight loss
- phase ii
- placebo controlled
- glycemic control